Tigermed-Jyton acquires NAMSA China

Tigermed-Jyton, a medical device CRO in China, has acquired NAMSA China, the Chinese branch of global MedTech CRO NAMSA, and entered into an exclusive China regional partnership and global collaboration with NAMSA.

“Tigermed-Jyton is excited to have NAMSA China joining our team.”tigermedgrp.com

• 1 source
• tigermedgrp.comTigermed-Jyton Announces Acquisition of NAMSA China and Global Strategic Partnership with NAMSAFeb 28, 2024

Summarized from public sources; check the original articles before acting on it.